Trademark Search in Canada

HUI ZHENG in Chinese Characters

View On IC.GC.CA

REGISTERED

on 1 Aug 2018

Last Applicant/ Owned by

Hanhui Pharmaceuticals Co., Ltd.

No. 2 Haizheng Road, Xukou TownFuyang District, Hangzhou City, Zhejiang Province

Serial Number

1724518 filed on 20^th Apr 2015

Registration Number

TMA1001968 registered on 1^st Aug 2018

Registration expiry Date

1^st Aug 2033

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

M5H3Y2

HUI ZHENG in Chinese Characters

Trademark usage description

vitamin preparations; medicines for human purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, Read More

Vienna Information

28 . 3 . 0

Inscriptions in Chinese, Japanese or Korean charactersInscriptions en caractères chinois, japonais ou coréens

Classification Information

Class [005]
Vitamin preparations; medicines for human purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, Acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, ovarian cancer, endometrial carcinoma, carcinoma of uterine cervix, head and neck cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, soft tissue sarcoma, melanoma tumor, Hodgkin's disease, testicular cancer, chorionic carcinoma, neuroblastoma, nephroblastoma, ewing sarcoma, rhabdomyosarcoma, Kaposi's sarcoma , and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; medicines for human purposes for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; medicines for human purposes for the treatment of lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and skin structure infections, bacterial septicemia, gynecological infections, febrile neutropenic infections in combination with an aminoglycoside, bone and joint infections and polymicrobic infections; medicines for human purposes for the treatment of urethritis, non-gonococcal urethritis (NGU), prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, superficial pyogenic infection, deep suppurative disease, acute and chronic bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, suppurative lung disease, syphilis, otitis media, nasosinusitis, hypognathadenitis, dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, peritonitis and septicemia, bacteremia; medicines for human purposes for the treatment of complicated intra-abdominal infections, complicated skin and skin structure infections and community-acquired pneumonia; medicines for human purposes for the treatment of intra-abdominal infection, lower respiratory tract infections, gynecological infections, septicaemia, urogenital tract infection, bone and joint infection, skin and skin structure infections, endocarditis and for many bacteria resistant to cephalosporin class, namely aerobic and anaerobic gram-positive and gram-negative bacterial infection caused by potent antimicrobial activity; bacteria resistant cephalosporin antibiotics namely cefazolin, cefoperazone, cefalotin, cefoxitin, cefotaxime, meng cephalosporin cefepime, hetotally and ceftriaxone; medicines for human purposes for the treatment of pneumonia hospital acquired pneumonia),urinary tract infection, gynecological infections endometritis pelvic inflammation), skin and skin structure infections, meningitis, septicaemia for patients with adult granulocytopenia syndrome associated with fever and Patients with multiple infection; medicines for human purposes for the treatment of burn, surgery wound infection, pneumonia, chronic bronchitis, nephropyelitis, urocystitis, peritonitis, septicemia; medicines for human purposes for the treatment of rheumatic disorders; medicines for human purposes for the treatment of collagen diseases; medicines for human purposes for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; medicines for human purposes for the treatment of allergic states; medicines for human purposes for the treatment of ophthalmic diseases; medicines for human purposes for the treatment of respiratory diseases; medicines for human purposes for the treatment of hematologic disorders; medicines for human purposes for the treatment of neoplastic diseases; medicines for human purposes for the treatment of edematous states; medicines for human purposes for the treatment of gastrointestinal diseases; medicines for human purposes for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; medicines for human purposes for the treatment of endocrine disorders; medicines for human purposes for the treatment of organ transplantation; medicines for human purposes for the treatment of shock therapy based on secondary adrenocortical insufficiency; capsules for pharmaceutical purposes for hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b); pharmaceutical preparations for human purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, ovarian cancer, endometrial carcinoma, carcinoma of uterine cervix, head and neck cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, soft tissue sarcoma, melanoma tumor, hodgkin's disease, testicular cancer, chorionic carcinoma, neuroblastoma, nephroblastoma, ewing sarcoma, rhabdomyosarcoma, Kaposi's sarcoma, and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; pharmaceutical preparations for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; pharmaceutical preparations for human purposes for the treatment of rheumatic disorders; pharmaceutical preparations for human purposes for the treatment of collagen diseases; pharmaceutical preparations for human purposes for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for human purposes for the treatment of allergic states; pharmaceutical preparations for human purposes for the treatment of ophthalmic diseases; pharmaceutical preparations for human purposes for the treatment of respiratory diseases; pharmaceutical preparations for human purposes for the treatment of hematologic disorders; pharmaceutical preparations for human purposes for the treatment of neoplastic diseases; pharmaceutical preparations for human purposes for the treatment of edematous states; pharmaceutical preparations for human purposes for the treatment of gastrointestinal diseases; pharmaceutical preparations for human purposes for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for human purposes for the treatment of endocrine disorders; pharmaceutical preparations for human purposes for the treatment of organ transplantation; pharmaceutical preparations for human purposes for the treatment of shock therapy based on secondary adrenocortical insufficiency; chemico-pharmaceutical preparations for human purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, ovarian cancer, endometrial carcinoma, carcinoma of uterine cervix, head and neck cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, soft tissue sarcoma, melanoma tumor, Hodgkin's disease, testicular cancer, chorionic carcinoma, neuroblastoma, nephroblastoma, ewing sarcoma, rhabdomyosarcoma, Kaposi's sarcoma, and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; chemico-pharmaceutical preparations for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis or a combination, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; chemico-pharmaceutical preparations for human purposes for the treatment of rheumatic disorders; chemico-pharmaceutical preparations for human purposes for the treatment of collagen diseases; chemico-pharmaceutical preparations for human purposes for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; chemico-pharmaceutical preparations for human purposes for the treatment of allergic states; chemico-pharmaceutical preparations for human purposes for the treatment of ophthalmic diseases; chemico-pharmaceutical preparations for human purposes for the treatment of respiratory diseases; pharmaceutical preparations for human purposes for the treatment of hematologic disorders; chemico-pharmaceutical preparations for human purposes for the treatment of neoplastic diseases; chemico-pharmaceutical preparations for human purposes for the treatment of edematous states; chemico-pharmaceutical preparations for human purposes for the treatment of gastrointestinal diseases; chemico-pharmaceutical preparations for human purposes for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; chemico-pharmaceutical preparations for human purposes for the treatment of endocrine disorders; chemico-pharmaceutical preparations for human purposes for the treatment of organ transplantation; chemico-pharmaceutical preparations for human purposes for the treatment of shock therapy based on secondary adrenocortical insufficiency; analgesics; drugs for medical purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, ovarian cancer, endometrial carcinoma, carcinoma of uterine cervix, head and neck cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, soft tissue sarcoma, melanoma tumor, hodgkin's disease, testicular cancer, chorionic carcinoma, neuroblastoma, nephroblastoma, ewing sarcoma, rhabdomyosarcoma, Kaposi's sarcoma, and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; drugs for medical purposes for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis; treatment of chronic congestive heart failure; medicines for human purposes for the treatment of lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and skin structure infections, bacterial septicemia, gynecological infections, febrile neutropenic infections, bone and joint infections and polymicrobic infections; medicines for human purposes for the treatment of urethritis, non-gonococcal urethritis (ngu), prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, superficial pyogenic infection, deep suppurative disease, acute and chronic bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, suppurative lung disease, syphilis, otitis media, nasosinusitis, hypognathadenitis, dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, peritonitis and septicemia, bacteremia; medicines for human purposes for the treatment of complicated intra-abdominal infections, complicated skin and skin structure infections and community-acquired pneumonia; medicines for human purposes for the treatment of intra-abdominal infection, lower respiratory tract infections, gynecological infections, septicaemia, urogenital tract infection, bone and joint infection, skin and skin structure infections, endocarditis and for many bacteria resistant to cephalosporin class, including aerobic and anaerobic gram-positive and gram-negative bacterial infection caused by potent antimicrobial activity; medicines for human purposes for the treatment of pneumonia hospital acquired pneumonia), urinary tract infection gynecological infections endometritis pelvic inflammation), skin and skin structure infections, meningitis, septicemia; medicines for human purposes for the treatment of burn, surgery wound infection, pneumonia, chronic bronchitis, nephropyelitis, urocystitis, peritonitis, septicaemia; drugs for medical purposes for the treatment of rheumatic disorders; drugs for medical purposes for the treatment of collagen diseases; drugs for medical purposes for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; drugs for medical purposes for the treatment of allergic states; drugs for medical purposes for the treatment of ophthalmic diseases; drugs for medical purposes for the treatment of respiratory diseases; drugs for medical purposes for the treatment of hematologic disorders; drugs for medical purposes for the treatment of neoplastic diseases; drugs for medical purposes for the treatment of edematous states; drugs for medical purposes for the treatment of gastrointestinal diseases; drugs for medical purposes for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; drugs for medical purposes for the treatment of endocrine disorders; drugs for medical purposes for the treatment of organ transplantation; drugs for medical purposes for the treatment of shock therapy based on secondary adrenocortical insufficiency; capsules for the treatment of hyperlipidemia caused by Primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b); sedatives; tranquillizers; biological preparations for medical purposes for pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis pelvic inflammation), skin and skin structure infections, meningitis, septicaemia; chemical preparations for pharmaceutical purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, Acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, Ovarian cancer, Endometrial carcinoma, carcinoma of uterine cervix, Head and neck cancer, gastric cancer, Liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, Soft tissue sarcoma, Melanoma tumor, Hodgkin's disease, Testicular cancer, Chorionic carcinoma, Neuroblastoma, nephroblastoma, Ewing sarcoma, rhabdomyosarcoma,Kaposi's sarcoma, and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; chemical preparations for pharmaceutical purposes for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; chemical preparations for pharmaceutical purposes for the treatment of rheumatic disorders; chemical preparations for pharmaceutical purposes for the treatment of collagen diseases; chemical preparations for pharmaceutical purposes for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; chemical preparations for pharmaceutical purposes for the treatment of allergic states; chemical preparations for pharmaceutical purposes for the treatment of ophthalmic diseases; chemical preparations for pharmaceutical purposes for the treatment of respiratory diseases; chemical preparations for pharmaceutical purposes for the treatment of hematologic disorders; chemical preparations for pharmaceutical purposes for the treatment of neoplastic diseases; chemical preparations for pharmaceutical purposes for the treatment of edematous states; chemical preparations for pharmaceutical purposes for the treatment of gastrointestinal diseases; chemical preparations for pharmaceutical purposes for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; chemical preparations for pharmaceutical purposes for the treatment of endocrine disorders; chemical preparations for pharmaceutical purposes for the treatment of organ transplantation; chemical preparations for pharmaceutical purposes for the treatment of shock therapy based on secondary adrenocortical insufficiency; chemical preparations for medical purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, ovarian cancer, endometrial carcinoma, carcinoma of uterine cervix, head and neck cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, soft tissue sarcoma, melanoma tumor, hodgkin's disease, testicular cancer, chorionic carcinoma, neuroblastoma, nephroblastoma, ewing sarcoma, rhabdomyosarcoma, Kaposi's sarcoma, and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; chemical preparations for medical purposes for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis or a combination, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; chemical preparations for medical purposes for the treatment of rheumatic disorders; chemical preparations for medical purposes for the treatment of collagen diseases; chemical preparations for medical purposes for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; chemical preparations for medical purposes for the treatment of allergic states; chemical preparations for medical purposes for the treatment of ophthalmic diseases; chemical preparations for medical purposes for the treatment of respiratory diseases; chemical preparations for medical purposes for the treatment of hematologic disorders; chemical preparations for medical purposes for the treatment of neoplastic diseases; chemical preparations for medical purposes for the treatment of edematous states; chemical preparations for medical purposes for the treatment of gastrointestinal diseases; chemical preparations for medical purposes for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; chemical preparations for medical purposes for the treatment of endocrine disorders; chemical preparations for medical purposes for the treatment of organ transplantation; chemical preparations for medical purposes for the treatment of shock therapy based on secondary adrenocortical insufficiency; antibiotics; injection (medicines) for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, ovarian cancer, endometrial carcinoma, carcinoma of uterine cervix, head and neck cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, soft tissue sarcoma, melanoma tumor, Hodgkin's disease, testicular cancer, chorionic carcinoma, neuroblastoma, nephroblastoma, ewing sarcoma, rhabdomyosarcoma, kaposi's sarcoma , and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; injection for the treatment of rheumatic disorders; injection for the treatment of collagen diseases; injection for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; injection for the treatment of allergic states; injection for the treatment of ophthalmic diseases; injection for the treatment of respiratory diseases; injection for the treatment of hematologic disorders; injection for the treatment of neoplastic diseases; injection for the treatment of edematous states; injection for the treatment of gastrointestinal diseases; injection for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; injection for the treatment of endocrine disorders; injection for the treatment of organ transplantation; injection for the treatment of shock therapy based on secondary adrenocortical insufficiency; tablets for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; tablets for the treatment of rheumatic disorders; tablets for the treatment of collagen diseases; tablets for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; tablets for the treatment of allergic states; tablets for the treatment of ophthalmic diseases; tablets for the treatment of respiratory diseases; tablets for the treatment of hematologic disorders; tablets for the treatment of neoplastic diseases; tablets for the treatment of edematous states; tablets for the treatment of gastrointestinal diseases;; tablets for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; tablets for the treatment of endocrine disorders; tablets for the treatment of organ transplantation; tablets for the treatment of shock therapy based on secondary adrenocortical insufficiency; bulk drugs for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis pelvic inflammation),skin and skin structure infections, meningitis, septicaemia; biochemical medicines for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis, pelvic inflammation, skin and skin structure infections, meningitis, septicemia; blood products for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis, pelvic inflammation), skin and skin structure infections, meningitis, septicemia; tinctures for medical purposes for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis pelvic inflammation), skin and skin structure infections, meningitis, septicemia; diagnostic preparations for medical purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, ovarian cancer, endometrial carcinoma, carcinoma of uterine cervix, head and neck cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, soft tissue sarcoma, melanoma tumor, hodgkin's disease, testicular cancer, chorionic carcinoma, neuroblastoma, nephroblastoma, ewing sarcoma, rhabdomyosarcoma, kaposi's sarcoma, and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; chemical preparations for medical purposes for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia fredrickson a and b), improving diabetes postprandial hyperglycemia long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; diagnostic preparations for medical purposes for the treatment of rheumatic disorders; diagnostic preparations for medical purposes for the treatment of collagen diseases; diagnostic preparations for medical purposes for the treatment of dermatologic diseases, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; diagnostic preparations for medical purposes for the treatment of allergic states; diagnostic preparations for medical purposes for the treatment of ophthalmic diseases; diagnostic preparations for medical purposes for the treatment of respiratory diseases; diagnostic preparations for medical purposes for the treatment of hematologic disorders; diagnostic preparations for medical purposes for the treatment of neoplastic diseases; diagnostic preparations for medical purposes for the treatment of edematous states; diagnostic preparations for medical purposes for the treatment of gastrointestinal diseases; diagnostic preparations for medical purposes for the treatment of nervous system, namely brain, movement, ocular motility and spinal cord diseases; diagnostic preparations for medical purposes for the treatment of endocrine disorders; diagnostic preparations for medical purposes for the treatment of organ transplantation; diagnostic preparations for medical purposes for the treatment of shock therapy based on secondary adrenocortical insufficiency; chemical reagents for veterinary purposes for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis, pelvic inflammation), skin and skin structure infections, meningitis, septicaemia; radium for medical purposes; radioactive substances for medical purposes; isotopes for medical purposes; radioactive medicines for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis, pelvic inflammation), skin and skin structure infections, meningitis, septicemia; oxygen baths; gases for medical purposes; oxygen for medical purposes; chemical conductors for electrocardiograph electrodes; human semen for artificial insemination; all purposes disinfectants; disinfectants; solutions for contact lenses; contact lens cleaning preparations; cleaning solutions for use with contact lenses; media for bacteriological cultures; bouillons for bacteriological cultures; bacteriological culture mediums; nutritive substances for microorganisms for medical use; cultures of microorganisms for medical and veterinary use; dietetic substances, namely, dietetic pasta, crackers, milk and sugar, for medical use in treating diabetes; food for babies; infant milk powder; air purifying preparations; disinfectants for chemical toilets; medicines for veterinary purposes for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis, pelvic inflammation), skin and skin structure infections, meningitis, septicemia; biological preparations for veterinary purposes for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis, pelvic inflammation), skin and skin structure infections, meningitis, septicaemia; chemical preparations for veterinary purposes for treatment of pneumonia hospital acquired pneumonia), urinary tract infection, gynecological infections endometritis, pelvic inflammation), skin and skin structure infections, meningitis, septicaemia; pesticides; vermin destroying preparations; disinfectant wipes; wadding for medical purposes; dental abrasives; dental mastics.

Classification kind code

Class [035]
Retail and wholesale store services featuring medicines, pharmaceutical preparations, sanitary preparations.

Classification kind code

Mark Details

Serial Number

1724518

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 8^th Mar 2018	Approved
Submitted for opposition 27 on 19^th Jan 2018	Approval Notice Sent
Submitted for opposition 15 on 16^th Nov 2017	Correspondence Created
Submitted for opposition 12 on 21^st Nov 2016	Extension of Time
Submitted for opposition 15 on 12^th May 2016	Correspondence Created
Submitted for opposition 22 on 3^rd Dec 2015	Search Recorded
Submitted for opposition 20 on 3^rd Dec 2015	Examiner's First Report
Submitted for opposition 31 on 24^th Apr 2015	Formalized
Submitted for opposition 1 on 21^st Apr 2015	Created
Submitted for opposition 30 on 20^th Apr 2015	Filed

HUI ZHENG in Chinese Characters

Classification Information

Classification kind code

Class [035]Retail and wholesale store services featuring medicines, pharmaceutical preparations, sanitary preparations.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [035]
Retail and wholesale store services featuring medicines, pharmaceutical preparations, sanitary preparations.